N-[(1R)-1-(1-cyclopentyl-4-oxo-5H-pyrazolo[3,4-d]pyrimidin-6-yl)ethyl]-5-[(3S)-dithiolan-3-yl]pentanamide

ID: ALA5267538

Chembl Id: CHEMBL5267538

Max Phase: Preclinical

Molecular Formula: C20H29N5O2S2

Molecular Weight: 435.62

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@@H](NC(=O)CCCC[C@H]1CCSS1)c1nc2c(cnn2C2CCCC2)c(=O)[nH]1

Standard InChI:  InChI=1S/C20H29N5O2S2/c1-13(22-17(26)9-5-4-8-15-10-11-28-29-15)18-23-19-16(20(27)24-18)12-21-25(19)14-6-2-3-7-14/h12-15H,2-11H2,1H3,(H,22,26)(H,23,24,27)/t13-,15+/m1/s1

Standard InChI Key:  KUSDMIVMZJMIPH-HIFRSBDPSA-N

Alternative Forms

  1. Parent:

    ALA5267538

    ---

Associated Targets(Human)

PDE9A Tchem Phosphodiesterase 9A (1131 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 435.62Molecular Weight (Monoisotopic): 435.1763AlogP: 4.13#Rotatable Bonds: 8
Polar Surface Area: 92.67Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.92CX Basic pKa: CX LogP: 2.45CX LogD: 2.43
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.48Np Likeness Score: -1.04

References

1. Nadur NF, de Azevedo LL, Caruso L, Graebin CS, Lacerda RB, Kümmerle AE..  (2021)  The long and winding road of designing phosphodiesterase inhibitors for the treatment of heart failure.,  212  [PMID:33412421] [10.1016/j.ejmech.2020.113123]

Source